Lil­ly says its weight loss drugs Moun­jaro and Zep­bound should­n't be used for 'cos­met­ic' rea­sons

Eli Lil­ly says it wants peo­ple to stop us­ing its drugs Zep­bound and Moun­jaro for “cos­met­ic weight loss,” pub­lish­ing a let­ter Thurs­day say­ing that it “stands against the use of its med­i­cines” for that pur­pose.

The two drugs are dif­fer­ent ap­provals of tirzepatide — Zep­bound for chron­ic weight man­age­ment and Moun­jaro for type 2 di­a­betes — which in stud­ies have record­ed weight loss ef­fects of up to 20% of body mass. The da­ta led to a so­cial me­dia tsuna­mi of per­son­al tes­ti­mo­ni­als and physi­cian videos, posts and claims around the use of Moun­jaro off-la­bel last year af­ter its type 2 ap­proval, and more re­cent­ly af­ter Zep­bound’s No­vem­ber obe­si­ty ap­proval.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER